Driving impairment in patients with movement disorders: examining the Baylor driving questionnaire by objective driving assessment [0.03%]
巴尔科尔驾驶问卷在运动障碍患者中的驾驶损伤评估：客观检测结果
Abhishek Lenka,Ruosha Li,Karim Makhoul et al.
Abhishek Lenka et al.
Background: The development of a screening tool to identify driving impairment in patients with movement disorders is an unmet need. Objective: ...
Lejla Paracka,Lan Ye,Jann Lübke et al.
Lejla Paracka et al.
Background: Several aspects of the occurrence of sleep disturbances in dystonia remain unclear. Here, we assessed sleep architecture with polysomnography (PSG) and investigated the association of specific findings with mo...
Effects of deep brain stimulation on non motor fluctuations in Parkinson's disease (assessed with the NMF severity scale) [0.03%]
丘脑底核深部电刺激对帕金森病非运动波动的影响(采用NMF量表评估)
Christian Matta,Camille Comet,Corentin Gaillard et al.
Christian Matta et al.
Background: Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) is a well-established treatment for motor fluctuations (MF) in Parkinson's disease (PD), but its impact on non-motor fluctuations (NMF) remains unc...
CSF tap test parameters and Short-Term outcomes in operated and non-operated patients with idiopathic normal pressure Hydrocephalus: A cohort study [0.03%]
腰穿试验参数与特发性正常压力脑积水手术及非手术患者的短期结局：队列研究
Sagar Poudel,Deepa Dash,Aparna Wagle Shukla et al.
Sagar Poudel et al.
Background: Normal Pressure hydrocephalus (NPH) is treated by ventriculoperitoneal shunting. The cerebrospinal fluid tap test (CSF-TT) is widely used to identify candidates for shunt surgery in idiopathic NPH (iNPH). This...
Efficacy and safety of repetitive transcranial magnetic stimulation on motor function, depression, and cognitive dysfunction in Parkinson's disease: A systematic review and meta-analysis of randomized controlled trials [0.03%]
重复经颅磁刺激对帕金森病运动功能、抑郁和认知障碍的有效性和安全性：系统评价和meta分析
Wenming Lu,Longxiang Yan,Chuangguo Li et al.
Wenming Lu et al.
Background: Parkinson's disease (PD) is a multifactorial neurodegenerative disease with a high prevalence worldwide, leading to motor and non-motor symptoms. Moreover, PD presents a progressive aggravation alongside time,...
Temporal patterns of motor and nonmotor symptom emergence in Parkinson's disease: a cluster analysis [0.03%]
帕金森病运动及非运动症状出现的时间规律：聚类分析
Yoko Sugimura,Toru Baba,Tomoko Totsune et al.
Yoko Sugimura et al.
Background: Parkinson's disease is a heterogeneous disorder characterized by a broad spectrum of motor and nonmotor symptoms. Recent studies suggest that the order of motor and nonmotor symptom development may indicate di...
Epidemiology of Parkinson's disease - Global burden of disease research from 1990 to 2021 and future trend predictions [0.03%]
1990至2021年全球疾病负担研究中的帕金森病流行病学及未来趋势预测
Sen Wang,Yujie Che,Yiqun Lin et al.
Sen Wang et al.
Background: Parkinson's disease (PD), a common neurodegenerative disorder, severely affects patients' quality of life. This study aims to update the assessment of PD's prevalence, incidence, mortality, and disability-adju...
Explore thyself: is it time for metacognition screening in clinical trials? [0.03%]
探索自我：临床试验中是否需要元认知筛查？
Andrew McGarry,Scott Y H Kim,Peggy Auinger et al.
Andrew McGarry et al.
Participant self-report has become increasingly important in the design of clinical trials for Parkinson's Disease (PD), resonating with the general sense that a person's account of their experience should be a prime consideration in evalua...
Alexander Calvano,Dilara Bingoel,Laura Beccaria et al.
Alexander Calvano et al.
We describe a young woman with a novel homozygous PARK7 mutation causing an early-onset and progressive parkinsonism-dystonia syndrome with poor dopaminergic response. Clinical heterogeneity among homozygous mutation carriers emphasises tha...
Validation of the Norwegian version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale [0.03%]
帕金森病统一评分量表(MDS-UPDRS)挪威版本的验证研究
Guido Alves,Yvonne Stavland Sørenes,Veslemøy Hamre Frantzen et al.
Guido Alves et al.
Introduction: The Movement Disorder Society-revised version of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) is the gold standard assessment for evaluating Parkinson's disease (PD) symptoms and severity, but a ...